Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

184
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
184
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Akkermansia muciniphila</i> alleviates diabetic cognitive impairment by inhibiting NLRP3 inflammasome activation and ameliorating hippocampal synaptic defects.

Food & function·2026
Same author

Hepatic SNHG9 links gut microbiota to liver protection in drug-induced liver injury.

Nature communications·2026
Same author

Author Correction: Different coffee consumption patterns affect HbA1c via propionic acid-producing gut microbiota.

NPJ science of food·2026
Same author

Serum Short-Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination.

Diabetes, obesity & metabolism·2026
Same author

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease.

iMetaOmics·2026
Same author

Acetate ameliorates glucolipid metabolic dysregulation and neuroinflammation in diabetic cognitive impairment via enhanced mitophagy.

Free radical biology & medicine·2026

Related Experiment Video

Updated: Jul 1, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.1K

Type 2 diabetes and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study.

Guangyi Xu1, Yanhong Xu2,3, Taohua Zheng2

  • 1School of Nursing, Qingdao University, Qingdao, 266071, China.

Scientific Reports
|March 1, 2024
PubMed
Summary

Type 2 diabetes mellitus (T2DM) has a negative causal effect on ulcerative colitis (UC), but not Crohn's disease (CD). This study used Mendelian randomization to explore the causal links between T2DM and inflammatory bowel disease (IBD).

Keywords:
Inflammatory bowel diseaseMendelian randomizationType 2 diabetes mellitus

More Related Videos

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Related Experiment Videos

Last Updated: Jul 1, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.1K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Area of Science:

  • Genetics
  • Gastroenterology
  • Endocrinology

Background:

  • Investigating the causal relationship between Type 2 Diabetes Mellitus (T2DM) and Inflammatory Bowel Disease (IBD) is crucial for understanding disease mechanisms and treatment strategies.
  • Mendelian randomization (MR) offers a robust method to infer causality using genetic variants as instrumental variables, minimizing confounding factors.

Approach:

  • This bidirectional two-sample MR study utilized genetic variants associated with T2DM and IBD (Ulcerative Colitis [UC] and Crohn's Disease [CD]) from large-scale genome-wide association studies (GWAS).
  • Multiple MR methods, including inverse variance weighting (IVW) and weighted median estimator, were employed, alongside sensitivity analyses (Steiger filtering, MR-PRESSO) to ensure result validity and assess pleiotropy.

Key Points:

  • A significant negative causal effect of T2DM on UC was identified (IVW OR: 0.882, p < 0.001).
  • No significant causal relationships were found between T2DM and CD, nor between IBD (UC or CD) and T2DM.
  • All genetic variants showed no evidence of significant horizontal pleiotropy, supporting the reliability of the findings.

Conclusions:

  • T2DM exerts a negative causal influence on UC, suggesting potential implications for managing IBD patients with diabetes.
  • The study does not support a causal link between T2DM and CD, or between IBD and T2DM.
  • Further research is warranted to fully elucidate the complex interplay between IBD and T2DM.